AmCad BioMed Corporation (TPEX:4188)

AmCad BioMed Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	925	1,415	1,422	849	1,030	1,027
Market Cap Growth	-34.82%	-0.45%	67.51%	-17.57%	0.26%	-19.90%
Enterprise Value	632	1,050	1,236	617	758	726
Last Close Price	14.60	22.35	26.12	15.60	18.93	18.88
PS Ratio	21.25	26.66	21.79	13.77	12.00	16.06
PB Ratio	1.52	2.13	2.98	1.63	1.78	1.73
P/TBV Ratio	2.00	2.82	4.63	2.48	2.62	2.57
EV/Sales Ratio	14.54	19.77	18.94	10.01	8.84	11.35
EV/FCF Ratio	-15.00	-	-	-	-	-
Debt / Equity Ratio	0.01	0.02	0.03	0.02	0.03	0.01
Asset Turnover	0.07	0.09	0.12	0.11	0.14	0.09
Inventory Turnover	0.73	0.73	1.00	1.06	1.17	1.04
Quick Ratio	14.98	15.37	12.23	12.26	14.43	8.38
Current Ratio	16.46	16.63	13.35	13.15	15.33	8.85
Return on Equity (ROE)	-8.91%	-9.26%	-8.65%	-9.89%	-4.58%	-6.98%
Return on Assets (ROA)	-6.70%	-6.69%	-6.33%	-6.87%	-3.61%	-5.06%
Return on Capital Employed (ROCE)	-11.70%	-9.70%	-11.10%	-12.20%	-6.20%	-9.20%
Earnings Yield	-5.24%	-3.57%	-3.19%	-6.30%	-2.48%	-3.45%
FCF Yield	-4.56%	-3.85%	-2.95%	-4.10%	-4.01%	-4.90%
Buyback Yield / Dilution	-14.80%	-8.42%	-0.01%	-	-0.09%	-0.36%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.